調剤薬局の世界市場:製品種類別(経口薬、局所薬、うがい薬、坐薬)、用途別(大人用薬、獣医用薬、子供用薬、老人用薬)、治療領域別(痛み管理、ホルモン補充療法)、地域別

◆英語タイトル:Global Compounding Pharmacy Market Size study, by Product Type (Oral Medication, Topical Medication, Mouthwashes, Suppositories), by Application (Medication for Adults, Medication for Veterinary, Medication for Children, Medication for Geriatric), by Therapeutic Area (Pain Management, Hormone Replacement Therapy) and Regional Forecasts 2019-2026
◆商品コード:BZW20AP039
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年4月22日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥514,800見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥650,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、調剤薬局の世界市場について、エグゼクティブサマリー、市場の定義・範囲、市場動向、産業分析、製品種類別(経口薬、局所薬、うがい薬、坐薬)分析、用途別(大人用薬、獣医用薬、子供用薬、老人用薬)分析、治療領域別(痛み管理、ホルモン補充療法)分析、地域別分析、競争状況などを総合的、多面的に調査・分析しております。
・エグゼクティブサマリー
・市場の定義・範囲
・市場動向
・産業分析
・調剤薬局の世界市場:製品種類別(経口薬、局所薬、うがい薬、坐薬)
・調剤薬局の世界市場:用途別(大人用薬、獣医用薬、子供用薬、老人用薬)
・調剤薬局の世界市場:治療領域別(痛み管理、ホルモン補充療法)
・調剤薬局の世界市場:地域別
・競争状況
【レポートの概要】

Global Compounding Pharmacy Market is valued approximately at USD 8056 million in 2018 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2019-2026. Since last few years, the development of compounding drugs has been increased in which the pharmacies have to deliver advanced compounding services to the patients. In pharmacology, compounding is the science of producing personalized medicines for patients. These drugs are prepared reliant on the physician’s prescription wherein, the individual components are mixed simultaneously as per the recommended dosage form, and strength. The competent pharmacists have a prominent role in the establishing the trust of patients on the healthcare system, reducing the risk of treatments and side effects, achieving better health outcomes, reducing treatment cost, safe access to the treatment and enhanced quality of life. Furthermore, the compounding pharmacy is more emphasized on patient- care instead of their traditional role of dispensing of medicines and improving the patient safety throughout the treatment management process. Growing acceptance of personalized medicines, rising number of patients visiting physicians to address chronic illness, and increasing geriatric population worldwide are the few factors responsible for high CAGR of the market over the forecast period. As per the United Nation’s report: World Population Prospect-The 2017 Revision, the population of people aged over 60 years is projected to increase from nearly 962 million in 2017 (13% of world population) to around 1.3 billion by 2030, globally. This, in turn, is expected to accelerate the demand of Compounding Pharmacy around the world. However, high costs of equipment and maintenance of sterile environment, along with shortage of skilled physicians are some major factors expected to hamper the growth of global Compounding Pharmacy market over the forecast period.

The regional analysis of global Compounding Pharmacy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the shortage of drugs reported by the FDA in the U.S. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period, due to growing pharmaceutical awareness among people, along with increasing geriatric population in the emerging economies such as China and India.

Major market player included in this report are:
Central Admixture Pharmacy Services
Fagron
Fresenius Kabi AG
PharMEDium Services, LLC
Institutional Pharmacy Solutions
Cantrell Drug Company
Triangle Compounding Pharmacies
Lorraine’s Pharmacy

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Oral Medication
Topical Medication
Mouthwashes
Suppositories

By Application:
Medication for Adults
Medication for Veterinary
Medication for Children
Medication for Geriatric

By Therapeutic Area:
Pain Management
Hormone Replacement Therapy

By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Compounding Pharmacy Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)
1.2.1. Compounding Pharmacy Market, by Product Type, 2017-2026 (USD Million)
1.2.2. Compounding Pharmacy Market, by Application, 2017-2026 (USD Million)
1.2.3. Compounding Pharmacy Market, by Therapeutic Area, 2017-2026 (USD Million)
1.2.4. Compounding Pharmacy Market, by Region, 2017-2026 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Compounding Pharmacy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Compounding Pharmacy Market Dynamics
3.1. Compounding Pharmacy Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Compounding Pharmacy Market Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Compounding Pharmacy Market, by Product Type
5.1. Market Snapshot
5.2. Global Compounding Pharmacy Market by Product Type, Performance – Potential Analysis
5.3. Global Compounding Pharmacy Market Estimates & Forecasts by Product Type 2016-2026 (USD Million)
5.4. Compounding Pharmacy Market, Sub Segment Analysis
5.4.1. Oral Medication
5.4.2. Topical Medication
5.4.3. Mouthwashes
5.4.4. Suppositories
Chapter 6. Global Compounding Pharmacy Market, by Application
6.1. Market Snapshot
6.2. Global Compounding Pharmacy Market by Application, Performance – Potential Analysis
6.3. Global Compounding Pharmacy Market Estimates & Forecasts by Application 2016-2026 (USD Million)
6.4. Compounding Pharmacy Market, Sub Segment Analysis
6.4.1. Medication for Adults
6.4.2. Medication for Veterinary
6.4.3. Medication for Children
6.4.4. Medication for Geriatric
Chapter 7. Global Compounding Pharmacy Market, by Therapeutic Area
7.1. Market Snapshot
7.2. Global Compounding Pharmacy Market by Therapeutic Area, Performance – Potential Analysis
7.3. Global Compounding Pharmacy Market Estimates & Forecasts by Therapeutic Area 2016-2026 (USD Million)
7.4. Compounding Pharmacy Market, Sub Segment Analysis
7.4.1. Pain Management
7.4.2. Hormone Replacement Therapy
Chapter 8. Global Compounding Pharmacy Market, Regional Analysis
8.1. Compounding Pharmacy Market, Regional Market Snapshot
8.2. North America Compounding Pharmacy Market
8.2.1. U.S. Compounding Pharmacy Market
8.2.1.1. Product Type breakdown estimates & forecasts, 2016-2026
8.2.1.2. Application breakdown estimates & forecasts, 2016-2026
8.2.1.3. Therapeutic Area breakdown estimates & forecasts, 2016-2026
8.2.2. Canada Compounding Pharmacy Market
8.3. Europe Compounding Pharmacy Market Snapshot
8.3.1. U.K. Compounding Pharmacy Market
8.3.2. Germany Compounding Pharmacy Market
8.3.3. Rest of Europe Compounding Pharmacy Market
8.4. Asia-Pacific Compounding Pharmacy Market Snapshot
8.4.1. China Compounding Pharmacy Market
8.4.2. India Compounding Pharmacy Market
8.4.3. Japan Compounding Pharmacy Market
8.4.4. Rest of Asia Pacific Compounding Pharmacy Market
8.5. Latin America Compounding Pharmacy Market Snapshot
8.5.1. Brazil Compounding Pharmacy Market
8.5.2. Mexico Compounding Pharmacy Market
8.6. Rest of The World Compounding Pharmacy Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Central Admixture Pharmacy Services
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Fagron
9.2.3. Fresenius Kabi AG
9.2.4. PharMEDium Services, LLC
9.2.5. Institutional Pharmacy Solutions
9.2.6. Cantrell Drug Company
9.2.7. Triangle Compounding Pharmacies
9.2.8. Lorraine’s Pharmacy
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL COMPOUNDING PHARMACY MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL COMPOUNDING PHARMACY MARKET
TABLE 3. GLOBAL COMPOUNDING PHARMACY MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)
TABLE 7. GLOBAL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY PRODUCT TYPE 2016-2026 (USD MILLION)
TABLE 8. GLOBAL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD MILLION)
TABLE 9. GLOBAL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY THERAPEUTIC AREA 2016-2026 (USD MILLION)
TABLE 10. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 11. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 12. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 13. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 14. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 15. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 16. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 17. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 18. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 19. GLOBAL COMPOUNDING PHARMACY MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 20. U.S. COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 21. U.S. COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 22. U.S. COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 23. CANADA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 24. CANADA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 25. CANADA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 26. UK COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 27. UK COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 28. UK COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 29. GERMANY COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 30. GERMANY COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 31. GERMANY COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 32. ROE COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 33. ROE COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 34. ROE COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 35. CHINA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 36. CHINA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 37. CHINA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 38. INDIA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 39. INDIA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 40. INDIA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 41. JAPAN COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 42. JAPAN COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 43. JAPAN COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 44. ROAPAC COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 45. ROAPAC COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 46. ROAPAC COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 47. BRAZIL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 48. BRAZIL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 49. BRAZIL COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 50. MEXICO COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 51. MEXICO COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 52. MEXICO COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 53. ROLA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 54. ROLA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 55. ROLA COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 56. ROW COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)
TABLE 57. ROW COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)
TABLE 58. ROW COMPOUNDING PHARMACY MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

FIG 1. GLOBAL COMPOUNDING PHARMACY MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL COMPOUNDING PHARMACY MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL COMPOUNDING PHARMACY MARKET, KEY TRENDS 2018
FIG 5. GLOBAL COMPOUNDING PHARMACY MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. GLOBAL COMPOUNDING PHARMACY MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL COMPOUNDING PHARMACY MARKET, PEST ANALYSIS
FIG 8. GLOBAL COMPOUNDING PHARMACY MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 10. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 11. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 12. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 13. GLOBAL COMPOUNDING PHARMACY MARKET BY SEGMENT, 2016 & 2026 (USD MILLION)
FIG 14. GLOBAL COMPOUNDING PHARMACY MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA COMPOUNDING PHARMACY MARKET 2016 & 2026 (USD MILLION)
FIG 16. EUROPE COMPOUNDING PHARMACY MARKET 2016 & 2026 (USD MILLION)
FIG 17. ASIA PACIFIC COMPOUNDING PHARMACY MARKET 2016 & 2026 (USD MILLION)
FIG 18. LATIN AMERICA COMPOUNDING PHARMACY MARKET 2016 & 2026 (USD MILLION)
FIG 19. GLOBAL COMPOUNDING PHARMACY MARKET, COMPANY MARKET SHARE ANALYSIS (2018)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[調剤薬局の世界市場:製品種類別(経口薬、局所薬、うがい薬、坐薬)、用途別(大人用薬、獣医用薬、子供用薬、老人用薬)、治療領域別(痛み管理、ホルモン補充療法)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆